Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap in January 2024

World Top 100 HealthCare Products Companies List by Market Cap in January 2024, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Largest HealthCare Products Companies in 2024
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2024, World Largest HealthCare Products Companies by Market Cap in 2024.
  1. National Vision Holdings

    World Rank (Jan-05-2024)
    6,543
    Market Cap (Jan-05-2024)
    1.590 Billion USD
    World Rank (Jul-30-2023)
    6,553
    Market Cap (Jul-30-2023)
    1.616 Billion USD
    World Rank (Dec-25-2022)
    4,030
    Market Cap (Dec-25-2022)
    3.057 Billion USD
    World Rank (Jan-07-2022)
    4,298
    Market Cap (Jan-07-2022)
    3.55 Billion USD
    Annual Revenue in USD
    2,079 Million USD
    Annual Net Income in USD
    128 Million USD
    Annual Results for Period Ending
    Jan-2022 ending year
    Headquarters Country
    Company Profile

    National Vision Holdings is a Optical Retail company. It is having over 1,100 stores in 44 states plus the District of Columbia and Puerto Rico, over 13,000 employees including a network of more than 2,000 optometrists. It is responsibility to help bring sight to the more than 2 billion people around the world in need of vision correction. The headquarters is in USA.

  2. Hanall Biopharma

    World Rank (Jan-05-2024)
    6,572
    Market Cap (Jan-05-2024)
    1.580 Billion USD
    World Rank (Jul-30-2023)
    9,371
    Market Cap (Jul-30-2023)
    0.883 Billion USD
    World Rank (Dec-25-2022)
    10,789
    Market Cap (Dec-25-2022)
    0.651 Billion USD
    World Rank (Jan-07-2022)
    10,233
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    76 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical Company with headquarters is in Seoul, South Korea.
  3. Hunan Jiudian Pharmaceutical

    World Rank (Jan-05-2024)
    6,585
    Market Cap (Jan-05-2024)
    1.574 Billion USD
    World Rank (Jul-30-2023)
    7,730
    Market Cap (Jul-30-2023)
    1.229 Billion USD
    World Rank (Dec-25-2022)
    8,071
    Market Cap (Dec-25-2022)
    1.066 Billion USD
    World Rank (Jan-07-2022)
    8,515
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Headquarters Country
  4. Global Blood Therapeutics

    World Rank (Jan-05-2024)
    6,607
    World Rank (Jul-30-2023)
    6,607
    World Rank (Dec-25-2022)
    6,607
    World Rank (Jan-07-2022)
    6,607
    Market Cap (Jan-07-2022)
    1.85 Billion USD
    Annual Revenue in USD
    194 Million USD
    Annual Net Income in USD
    -303 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Global Blood Therapeutics is a Biopharmaceutical Company. It is to transform the treatment of sickle cell disease and an overlooked rare condition and help address the urgent needs of the community. The company medicine is the first treatment approved by the FDA to target an underlying cause of SCD. The headquarters is in USA.

  5. Taro Pharmaceutical Industries

    World Rank (Jan-05-2024)
    6,615
    Market Cap (Jan-05-2024)
    1.562 Billion USD
    World Rank (Jul-30-2023)
    7,238
    Market Cap (Jul-30-2023)
    1.379 Billion USD
    World Rank (Dec-25-2022)
    7,898
    Market Cap (Dec-25-2022)
    1.107 Billion USD
    World Rank (Jan-07-2022)
    6,638
    Market Cap (Jan-07-2022)
    1.83 Billion USD
    Annual Revenue in USD
    561 Million USD
    Annual Net Income in USD
    58 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Taro Pharmaceutical Industries is a Research Based International Pharmaceutical company. The headquarters is in USA.
  6. Supernus Pharmaceuticals

    World Rank (Jan-05-2024)
    6,703
    Market Cap (Jan-05-2024)
    1.522 Billion USD
    World Rank (Jul-30-2023)
    6,453
    Market Cap (Jul-30-2023)
    1.657 Billion USD
    World Rank (Dec-25-2022)
    5,403
    Market Cap (Dec-25-2022)
    2.026 Billion USD
    World Rank (Jan-07-2022)
    7,241
    Market Cap (Jan-07-2022)
    1.58 Billion USD
    Annual Revenue in USD
    667 Million USD
    Annual Operating Income in USD
    46 Million USD
    Annual Net Income in USD
    61 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Supernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.
  7. Eris Lifesciences

    World Rank (Jan-05-2024)
    6,710
    Market Cap (Jan-05-2024)
    1.518 Billion USD
    World Rank (Jul-30-2023)
    7,521
    Market Cap (Jul-30-2023)
    1.283 Billion USD
    World Rank (Dec-25-2022)
    7,956
    Market Cap (Dec-25-2022)
    1.092 Billion USD
    World Rank (Jan-07-2022)
    7,843
    Market Cap (Jan-07-2022)
    1.37 Billion USD
    Annual Revenue in USD
    166 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Eris Lifesciences is a pharmaceutical company with a generation of actionable medical evidence through initiatives such as the India Heart Study (IHS) and India Diabetes Study (IDS). The company annual revenue is 13,470 million INR and annual net income is 4,061 million INR for year ending March 2021. The headquarters is in India.
  8. Constellation Pharmaceuticals

    World Rank (Jan-05-2024)
    6,721
    World Rank (Jul-30-2023)
    6,721
    World Rank (Dec-25-2022)
    6,721
    World Rank (Jan-07-2022)
    6,721
    Annual Revenue in USD
    8,614 Million USD
    Annual Net Income in USD
    1,998 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Constellation Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company using expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression.
  9. Zhejiang Jingxin Pharmaceutical

    World Rank (Jan-05-2024)
    6,802
    Market Cap (Jan-05-2024)
    1.487 Billion USD
    World Rank (Jul-30-2023)
    6,931
    Market Cap (Jul-30-2023)
    1.482 Billion USD
    World Rank (Dec-25-2022)
    6,835
    Market Cap (Dec-25-2022)
    1.400 Billion USD
    World Rank (Jan-07-2022)
    7,970
    Market Cap (Jan-07-2022)
    1.34 Billion USD
    Headquarters Country

Share

Ads